Author: Manuel Delgado

Stable Green Electroluminescence from an Iridium Tris-Heteroleptic Ionic Complex

An ionic tris-heteroleptic iridium complex gives green light-emitting electrochemical cells (LECs) with unprecedented performances for this part of the visible spectrum. The devices are very bright (>1000 cd m–2), efficient (∼3%), and stable (>55 h). The novel complex is prepared using a new and efficient synthetic procedure. We show that there is a mixed orbital formation originating from the two different orthometalating ligands resulting in photophysical properties that lie between those of its two bis-heteroleptic analogs. Therefore, tris-heteroleptic complexes provide new avenues for fine-tunning the emission properties and to bridge gaps between a series of bis-heteroleptic complexes.

research product

Lucrecia Borgia : drama en cinco actos

research product

Assessing the impact of COVID-19 on liver cancer management (CERO-19)

[Background & Aims] The coronavirus disease 2019 (COVID-19) pandemic has posed unprecedented challenges to healthcare systems and it may have heavily impacted patients with liver cancer (LC). Herein, we evaluated whether the schedule of LC screening or procedures has been interrupted or delayed because of the COVID-19 pandemic.

research product

A deep-blue emitting charged bis-cyclometallated iridium(iii) complex for light-emitting electrochemical cells

We report here a new cationic bis-cyclometallated iridium(III) complex, 1, with deep-blue emission at 440 nm and its use in Light-emitting Electrochemical Cells (LECs). The design is based on the 2′,6′-difluoro-2,3′-bipyridine skeleton as the cyclometallating ligand and a bis-imidazolium carbene-type ancillary ligand. Furthermore, bulky tert-butyl substituents are used to limit the intermolecular interactions. LECs have been driven both at constant voltage (6 V) and constant current (2.5 mA cm−2). The performances are significantly improved with the latter method, resulting overall in one of the best reported greenish-blue LECs having fast response (17 s), light intensity over 100 cd m−2 an…

research product

Tuning the photophysical properties of cationic iridium(iii) complexes containing cyclometallated 1-(2,4-difluorophenyl)-1H-pyrazole through functionalized 2,2′-bipyridineligands: blue but not blue enough

Four new heteroleptic iridium(III) complexes in the family [Ir(dfppz)(2)((NN)-N-boolean AND)](+), where Hdfppz = 1-(2,4-difluorophenyl)-1H-pyrazole and (NN)-N-boolean AND = 6-phenyl-2,2'-bipyridine (1), 4,4'-(di-tert-butyl)-6-phenyl-2,2'-bipyridine (2), 4,4'-(di-tert-butyl)-6,6'-diphenyl-2,2'-bipyridine (3) and 4,4'-bis(dimethylamino)-2,2'-bipyridine (4), have been synthesized as the hexafluoridophosphate salts and fully characterized. Single crystal structures of ligand 3 and the precursor [Ir-2(dfppz)(4)(mu-Cl)(2)] have been determined, along with the structures of the complexes 4{[Ir(dfppz)(2)(1)][PF6]}center dot 3CH(2)Cl(2), [Ir(dfppz)(2)(3)][PF6]center dot CH2Cl2 and [Ir(dfppz)(2)(4)][…

research product

International and multicenter real‐world study of sorafenib‐treated patients with hepatocellular carcinoma under dialysis

Background & Aims: Information on safety and efficacy of systemic treatment in patients with hepatocellular carcinoma (HCC) under dialysis are limited due to patient exclusion from clinical trials. Thus, we aimed to evaluate the rate, prevalence, tolerability, and outcome of sorafenib in this population. Methods: We report a multicenter study comprising patients from Latin America and Europe. Patients treated with sorafenib were enrolled; demographics, dose modifications, adverse events (AEs), treatment duration, and outcome of patients undergoing dialysis were recorded. Results: As of March 2018, 6156 HCC patients were treated in 44 centres and 22 patients were concomitantly under dial…

research product

Convergence of Theory and Experiment on the Role of Preorganization, Quantum Tunneling, and Enzyme Motions into Flavoenzyme-Catalyzed Hydride Transfer

Hydride transfer is one of the most common reactions catalyzed by enzymatic systems, and it has become an object of study because of possible significant quantum tunneling effects. In the present work, we provide a combination of theoretical QM/MM simulations and experimental measurements of the rate constants and kinetic isotopic effects (KIEs) for the hydride transfer reaction catalyzed by morphinone reductase, MR. Quantum mechanical tunneling coefficients, computed in the framework of variational transition-state theory, play a significant role in this reaction, reaching values of 23.8 ± 5.5 for the lightest isotopologue—one of the largest values reported for enzymatic systems. This pred…

research product

Effectiveness, safety/tolerability of OBV/PTV/r ± DSV in patients with HCV genotype 1 or 4 with/without HIV-1 co-infection, chronic kidney disease (CKD) stage IIIb-V and dialysis in Spanish clinical practice - Vie-KinD study.

Background and aims Limited data are available on the effectiveness and tolerability of direct-acting antivirals (DAAs) therapies in the real world for HCV-infected patients with comorbidities. This study aimed to describe the effectiveness of OBV/PTV/r +/- DSV (3D/2D regimen) with or without ribavirin (RBV) in HCV or HCV/HIV co-infected patients with GT1/GT4 and CKD (IIIb-V stages), including those under hemodialysis and peritoneal dialysis in routine clinical practice in Spain in 2015. Material and methods Non-interventional, retrospective, multicenter data collection study in 31 Spanish sites. Socio-demographic, clinical variables, study treatment characteristics, effectiveness and toler…

research product